Yoon Ji Choi

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

Hyeyoon Chang, Jung Sun Kim, Yoon Ji Choi et al. · OncoTargets and Therapy · 2017 · 58 citations · Full text

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

Xiao–Tang Kong, Nhung Nguyen, Yoon Ji Choi et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 57 citations · Full text

Neuro-oncology, Radiation Medicine, Radiation Therapy +10

Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: a cross-sectional study

Jeongki Paek, Yoon Ji Choi · BMJ Open · 2019 · 54 citations · Full text

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

Y-K. Kang, Changhoon Yoo, B-Y. Ryoo et al. · British Journal of Cancer · 2013 · 53 citations · Full text